Nocimed is now Aclarion.

AUTHOR: Admin

Aclarion to Present 2-year Follow-up Data Linking Nociscan to Better Surgical Outcomes

Superior Clinical Outcomes for NociscanTM Proving to be Durable at Two Years Two Year Results and the Schedule of Future Clinical Trials to be Outlined at the Annual State of Spine Surgery Think Tank 2022 San Mateo, CA –Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and […]

Aclarion, Inc. Announces Closing of $9.4 Million Initial Public Offering

SAN MATEO, CA, April 26, 2022 — Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), artificial intelligence and a proprietary biomarker to optimize clinical treatments for low back and neck pain, today announced the closing of its previously announced initial public offering of 2,165,000 […]

Aclarion, Inc. Announces Listing on Nasdaq and Pricing of $9.4 Million Initial Public Offering

SAN MATEO, CA, April 21, 2022 — Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy (“MRS”), artificial intelligence and a proprietary biomarker to optimize clinical treatments for low back and neck pain, today announced the pricing of its initial public offering of 2,165,000 shares of […]

Request Info or Schedule a Demo

This field is for validation purposes and should be left unchanged.

Aclarion
951 Mariners Island Blvd #300
San Mateo, CA 94404

info@aclarion.com

(650) 241-1741